No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Renal elimination of sodium stibogluconate has been found to be similar to the rate of glomerular filtration and there is little potential for an interaction with emtricitabine and tenofovir via competition for active renal transport mechanisms.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking